ESC 365 - Associate Professor Maciej Wybraniec

Speaker illustration

Associate Professor Maciej Wybraniec

School of Medicine in Katowice, Medical University of Silesia, Katowice (Poland)

Member of:

Presentations Articles

Efficacy and safety of antiarrhythmic drugs for pharmacological cardioversion of atrial fibrillation depending on gender: a subanalysis of CANT II Study

Event: ESC Congress 2023

Topic: Antiarrhythmic Drug Treatment

Session: Cardioversion, antiarrhythmics and antithrombotic management of atrial fibrillation

Clinical characteristics and risk factors of in-hospital mortality among patients undergoing percutaneous pericardiocentesis

Event: ESC Congress 2023

Topic: Complications

Session: Coronary diagnostics and interventions

Heart failure and the risk of left atrial thrombus formation in patients with atrial fibrillation and atrial flutter: insights from the LATTEE registry

Event: ESC Congress 2022

Topic: Oral Anticoagulation

Session: Stroke prevention in atrial fibrillation

Pharmacological cardioversion of recent-onset atrial fibrillation in patients with chronic kidney disease: sub-analysis of the CANT Study

Event: ESC Congress 2021 - The Digital Experience

Topic: Rhythm Control, Cardioversion

Session: Atrial fibrillation e-posters

CHLD score, a new score based on traditional risk factor evaluation and long-term cardiovascular outcomes in patients with systemic sclerosis

Event: ESC Congress 2021 - The Digital Experience

Topic: Autoimmune/Chronic Inflammatory Disorders and Heart Disease

Session: Cardiovascular Disease in Special Populations ePosters

Antazoline for pharmacological cardioversion of atrial fibrillation: the results of the high-volume multicenter CANT study

Event: ESC Congress 2020

Topic: Rhythm Control, Cardioversion

Session: Atrial Fibrillation ePosters

Managed Care after Acute Myocardial Infarction (MC-AMI) reduces MACE by 45% in 3-month follow-up - results form Poland's National Health Fund program of post-MI care. A single center analysis

Event: ESC Congress 2019

Topic: Secondary Prevention

Session: Risk factors and prevention

Efficacy of comprehensive Managed Care after Acute Myocardial Infarction (MC-AMI) in a long-term follow-up - preliminary experience of a single high-volume center.

Event: ESC Congress 2019

Topic: Secondary Prevention

Session: Risk factors and prevention

Propensity score matched analysis of antazoline mesylate vs. amiodarone or propafenone for pharmacological cardioversion of short-duration atrial fibrillation

Event: ESC Congress 2019

Topic: Rhythm Control, Cardioversion

Session: Drug treatment for atrial fibrillation

Renal resistive index is associated with adverse cardiovascular events at 24 months in patients with coronary artery disease submitted to coronary angiography

Event: ESC Congress 2018

Topic: Noninvasive Diagnostic Methods

Session: Coronary artery disease : diagnosis pharmacotherapy and revascularisation

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources